SWM
RPRX icon

SHP Wealth Management’s Royalty Pharma RPRX Stock Holding History

SHP Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Buy
30
+21
+233% +$1.09K ﹤0.01% 1448
2026
Q1 		$439 Hold
9
– – ﹤0.01% 1644
2025
Q4 		$352 Buy
+9
New +$343 ﹤0.01% 1403

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SHP Wealth Management's RPRX Position: Q2 2026 in Review

SHP Wealth Management increased its Royalty Pharma (RPRX) stake by 233% in Q2 2026, buying an estimated $1.09K and bringing the position to 30 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

SHP Wealth Management first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • SHP Wealth Management held 30 shares of Royalty Pharma worth $1.67K as of Q2 2026.
  • SHP Wealth Management bought 21 Royalty Pharma shares in Q2 2026, an estimated $1.09K.
  • Royalty Pharma made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1448 holding.
  • SHP Wealth Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.